Both in Pharmaceuticals
AbCellera Biologics vs Xenon Pharmaceuticals
Over the past year ABCL returned +121.1% and XENE returned −10.8%; their daily moves had a correlation of 0.15.
ABCL +121.1% XENE −10.8%Growth of $1, one year, split-adjusted
| Metric | ABCL | XENE |
|---|---|---|
| Price | $12.27 | $37.41 |
| Market cap | $3.98B | $3.62B |
| Today | −6.19% | −0.35% |
| 1 month | −11.8% | −3.9% |
| 6 months | +177.0% | −33.4% |
| Year to date | +258.8% | −16.5% |
| 1 year | +118.3% | −11.6% |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −1368.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 60.1× | — |
| Net cash | $540.1M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 94.9% | 82.3% |
| Short % of float | 14.5% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).